A Phase 3 Trial of DT120 for Generalized Anxiety Disorder (Voyage)
A Phase 3 Trial of DT120 for Generalized Anxiety Disorder (Voyage)
Active, not recruiting · NCT06741228 · Registry updated 2026-09-25Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Phase 3 Trial of DT120 for Generalized Anxiety Disorder (Voyage) | anxiety disorder, generalized anxiety disorder, psychiatric disorder | Active, not recruiting | Phase 3 | 2026-09-25 | NCT06741228 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Definium Therapeutics US, Inc. | 5 |
34 results · Page 1 of 2
Research sites
Swipe the table sideways for more columns.